Original news and analysis on international IP policy
A battle broke out yesterday at the World Health Organization over whether it should continue its relationship with an in-house anti-counterfeiting law enforcement and customs group, and what that decision might mean for the role of the organisation in the fight against fake medicines.
Discussion at the annual World Health Assembly on counterfeit medicines may prove lively as stakeholders continue to raise concerns that the term “counterfeit” will confuse protecting patients from unsafe drugs with protecting trademarks from infringement. And an industry-led event in the lead-up to the WHA said counterfeit medicines pose great risks and will require a coordinated international response.
Two groups this week are urging the World Health Assembly to address access to diagnosis, treatment and new drugs, for a tropical disease that is the leading parasitic killer in the Americas. At a side event on the first day of the assembly, civil society actors also expressed concern about the shrinking input of civil society in the annual WHO members’ meeting.
A critical report on financing research and development of medicines for the world's poorest was created without transparency, failed to live up to its mandate, and did not address the potential threat that intellectual property rights can pose to access to drugs, developing countries said today at the World Health Assembly. A proposal by a group of Latin American countries for a new intergovernmental working group was not accepted by developed countries and others and quick informal consultations began to work out differences before the end of the assembly this week.
World Health Organization Director General Margaret Chan opened the annual World Health Assembly today with a welcome of the transparency in the “most closely watched pandemic in history,” and how the drive to meet the UN Millennium Development Goals would unleash a “host of innovations for improving health, especially among the poorest,” adding a call for vaccines as one of the “best life-saving buys on offer.”
How to proceed with the results of an initiative aimed at finding real alternatives for innovative health research financing is on the agenda at next week's World Health Assembly (WHA). The assembly also is expected to approve the continuation of a working group on pandemic influenza preparedness.
The international policy debate over counterfeit medicines and legitimate generics escalated today. Brazil and India took the first step in the World Trade Organization dispute settlement process for treatment of generics medicines falsely labelled counterfeit in Europe, and non-governmental organisations from both sides of the issue issued new releases stating their positions on the issues at the neighbouring World Health Organization.
Three new documents from the World Health Organization programme on intellectual property and innovation obtained by Intellectual Property Watch provide new evidence on how technology transfer is working, analyse research prioritisation at the WHO, and indicate progress on a monitoring and evaluation strategy for the programme's continued implementation, according to a preliminary reading.
An alternative initiative to promote access to medicine with a method mimicking market mechanisms means to create additional incentives for health innovation, authors of the proposal said yesterday. But other health actors have reservations.
A public event was organised yesterday to discuss how the Health Impact Fund (HIF) could fit within existing structures and what challenges it could face.
While the Anti-Counterfeiting Trade Agreement (ACTA) is getting a lot of attention with its draft consolidated version just published, there is another convention dealing with one major aspect it was always said ACTA would tackle. The Medicrime Convention of the Council of Europe sets the first international standard for criminalising the manufacturing and distribution of counterfeited medicine risking public health. And Medicrime will overtake ACTA, as the draft convention text is ready to be signed by the Committee of Ministers in May and be opened for signature in November.